{
    "eid": "2-s2.0-85041124153",
    "title": "In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study",
    "cover-date": "2018-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neuroscience (all)",
            "@code": "2800",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Toxicology",
            "@code": "3005",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Anxiety",
        "Depression",
        "Immune",
        "Inflammation",
        "Schizophrenia",
        "Tryptophan catabolites"
    ],
    "authors": [
        "Buranee Kanchanatawan",
        "Supaksorn Thika",
        "Sunee Sirivichayakul",
        "Andr\u00e9 F. Carvalho",
        "Michel Geffard",
        "Michael Maes"
    ],
    "citedby-count": 36,
    "ref-count": 52,
    "ref-list": [
        "Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis",
        "Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression",
        "Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways",
        "Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old",
        "Associations between severity of anxiety and clinical and biological features of major affective disorders",
        "From prediction error to psychosis: ketamine as a pharmacological model of delusions",
        "The two-syndrome concept: origins and current status",
        "Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia",
        "A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis",
        "Circulating antibodies to IDO/THO pathway metabolites in Alzheimer\u2019s disease",
        "Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder",
        "Unrestricted item factor analysis and some relations with item response theory",
        "Episodic memory and impairment of an early encoding process in schizophrenia",
        "The assessment of anxiety states by rating",
        "A rating scale for depression",
        "Negative symptoms and cognitive deficits: what is the nature of their relationship?",
        "The enduring effects of depressive thoughts on working memory",
        "The diagnostic concept of schizophrenia: its history, evolution, and future prospects",
        "Mood and anxiety disorders in chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome: results from the LifeLines cohort study",
        "Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway",
        "Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia",
        "Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs",
        "Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition",
        "The positive and negative syndrome scale (PANSS) for schizophrenia",
        "Cognitive impairment in schizophrenia",
        "The schedule for the deficit syndrome: an instrument for research in schizophrenia",
        "Secondary negative symptoms \u2014 A review of mechanisms, assessment and treatment",
        "The effects of depression and anxiety on memory performance",
        "Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue",
        "Association of neurocognition, anxiety, positive and negative symptoms with coping preference in schizophrenia spectrum disorders",
        "Functional\u201d or \u201cpsychosomatic\u201d symptoms, e.g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression",
        "An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways",
        "Evidence for the existence of major depression with and without anxiety features",
        "IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression",
        "Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression",
        "Long-term monomorphism of negative and positive schizophrenic episodes. In: negative symptoms in schizophrenia: relationship to positive symptoms and outcome",
        "Methodological problems in identifying and measuring first-rank symptoms of schizophrenia",
        "Attention and memory deficits in schizophrenia: the role of symptoms of depression",
        "The brief psychiatric rating scale",
        "The assessment of neuropsychological functioning in schizophrenia",
        "Organizational and visual memory deficits in schizophrenia and bipolar psychoses using the Rey-Osterrieth complex figure: effects of duration of illness",
        "The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study",
        "The role of negative symptoms and cognitive dysfunction in schizophrenia outcome",
        "The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part V. A normative study of the neuropsychological battery",
        "Neurocognitive impairments in deficit and non-deficit schizophrenia and their relationships with symptom dimensions and other clinical variables",
        "A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale)"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60015765",
            "affilname": "Centre for Addiction and Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015765",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Saint-Jean-d'Illac",
            "@id": "105889154",
            "affilname": "GEMAC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/105889154",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Talence",
            "@id": "101932858",
            "affilname": "IDRPHT",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101932858",
            "affiliation-country": "France"
        }
    ],
    "funding": [
        "Asahi Glass Foundation",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}